The QualityStocks Daily Thursday, September 21st, 2023

Today's Top 3 Investment Newsletters

Tiny Gems(NIR) $0.2937 +40.53%

MarketClub Analysis(YCRM) $0.0052 +20.93%

Schaeffer's(SPLK) $144.4300 +20.77%

The QualityStocks Daily Stock List

Northwest Biotherapeutics (NWBO)

RedChip, QualityStocks, The Street, TradersPro, BUYINS.NET, CoolPennyStocks, HotOTC, MarketBeat, WealthMakers, BullRally, Stock Rich, Market Report, InvestorPlace, AllPennyStocks, StockEgg, FeedBlitz,, OTCPicks, Penny Invest, Investment U, Streetwise Reports, Promotion Stock Secrets, SmallCapNetwork, Wall Street Corner, TopPennyStockMovers, StreetInsider, StockRich, StockPicksNYC, Stock Traders Chat, Standout Stocks, PureActionStocks, SmallCapVoice, MicrocapVoice, Schaeffer's, Red Chip, Pennybuster, PennyInvest, PennyStockLive, PennyStockVille, Wealthpire Inc. and MadPennyStocks reported earlier on Northwest Biotherapeutics (NWBO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics Inc. (OTCQB: NWBO) is a biotechnology firm that is focused on the development of immune therapies for cancer.

The firm has its headquarters in Bethesda, Maryland and was incorporated in 1996, on March 18th by Alton L. Boynton. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has two companies in its corporate family and serves consumers internationally, with a focus on the United States.

The company uses its expertise in the biology of dendritic cells to develop cancer therapies. Dendritic cells are a type of white blood cell that activates an individual’s immune system. The company is focused on developing therapies that have fewer side effects, as currently approved treatments for cancer cause undesirable effects and are mostly ineffective.

The enterprise uses a technology platform known as DCVax to develop its products. The platform utilizes activated dendritic cells to mobilize a patient’s immune system to eliminate cancer cells. Its product pipeline comprises of DC-Vax-Direct, which is undergoing phase I/II clinical trials testing its efficacy in treating inoperable solid tumors. It also develops DCVax-L, which is in phase 3 clinical trials evaluating its effectiveness in treating Glioblastoma multiforme brain cancer.

The company will soon begin producing DCVax products at its Sawston manufacturing facility, after it was issued with an HTA license. Once production ramps up, the company’s revenue is set to increase with product distribution also bringing in more investments into the company, which will have a positive effect on its growth.

Northwest Biotherapeutics (NWBO), closed Thursday's trading session at $0.995, up 16.3743%, on 7,748,230 volume. The average volume for the last 3 months is 64,053 and the stock's 52-week low/high is $0.4001/$1.27.

Creative Realities (CREX)

QualityStocks, MarketBeat, MarketClub Analysis, StockMarketWatch, StockEarnings, InvestorPlace, TradersPro and StreetInsider reported earlier on Creative Realities (CREX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Creative Realities Incorporated (NASDAQ: CREX) (FRA: 4U7) is engaged in the provision of digital marketing technology solutions to enterprises, individual retail brands, retail firms and other bodies in Canada and the U.S.

The firm, which is a subsidiary of Slipstream Communications LLC, has its headquarters in Louisville, Kentucky. It was incorporated in 1997 and operates in the communications sector, under the media industry in the advertising and marketing sub-industry.

The enterprise’s solutions and technology include kiosks and advisors, interactive digital shopping assistants, omni-channel customer engagement systems and digital merchandising systems, among other interactive marketing technologies (including beaconing, point-of-sale transactions, social media, mobile and web-based media) which allow businesses to engage with customers.

The company also offers software licenses, field services, implementation, engineering, software development, content development and production, experience design and consulting, as well as support and maintenance services related to its managed systems, software and solutions. It sells its solutions to the pharmacy retail industry, mobile operators, mass merchants, luxury, gaming, financial services, quick service restaurants/food service, fitness, fashion, electronics, digital out-of-home, department stores, CPG, beauty, children/baby, baking, accessories and apparel and the automotive industries. The company’s customers include Travelocity, Nine West, Thomson Reuters, Sunglass Hut, KFC, Estee Lauder, Ford, Adidas, Carnival, Calvin Klein, Chrysler Canada, Rite Aid and Macy’s.

The firm recently announced its first quarter financial results, which highlight that it achieved breakeven operating results. It is currently working on strengthening its competitive position and market perception through new opportunities which are bound to boost growth as well as investments into the firm.

Creative Realities (CREX), closed Thursday's trading session at $1.74, up 12.987%, on 63,486 volume. The average volume for the last 3 months is 205,553 and the stock's 52-week low/high is $1.46/$4.00.

Intrusion Inc. (INTZ)

QualityStocks, MarketBeat,, TradersPro, PennyOmega, OTCPicks and OTC Markets Group reported earlier on Intrusion Inc. (INTZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Intrusion Inc. (NASDAQ: INTZ) is engaged in the provision of network security solutions and services.

The firm has its headquarters in Richardson, Texas and was incorporated in September 1983 by G. Ward Paxton and T. Joe Head. Prior to its name change in November 2001, the firm was known as Inc. It operates as part of the software and tech services industry, under the technology sector, in the software sub-industry.

The company specializes in the development and marketing of advanced persistent threat detection, cybercrime, data mining and entity identification products. It serves firms ranging from mid-market to large enterprises, local and state government entities and U.S. federal government entities, via value-added resellers and its direct sales force.

The enterprise’s products include a network monitoring solution known as INTRUSION Savant which identifies suspicious traffic; a data tool which holds an inventory of network enrichments and selectors to support forensic investigations known as INTRUSION TraceCop; and a network detection and response security-as-a-service solution that identifies and stops attacks and ransomware dubbed INTRUSION Shield. In addition to this, the enterprise provides post-and pre-sales support services like system installation and technical consulting services, and is involved in the resale of commercially available servers and computers from different vendors.

The global recognition and interest in the firm’s Shield solution has been growing, with the firm recently revealing that is now focused on entering into constructive long-term strategic agreements which will allow the company to achieve its operating objectives, maximize shareholder value and help it grow.

Intrusion Inc. (INTZ), closed Thursday's trading session at $0.4001, up 11.108%, on 558,862 volume. The average volume for the last 3 months is 26,289 and the stock's 52-week low/high is $0.32/$5.77.

Vemanti Group (VMNT)

Profitable Trader Authority, PennyStockScholar, OTCtipReporter, SmallCapVoice, TradersPro, StockPicksNYC, PennyStockAlertsNYC and Innovative Marketing reported earlier on Vemanti Group (VMNT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vemanti Group Inc. (OTCQB: VMNT) is a fintech firm that is focused on developing digital banking and fintech applications for the small to medium enterprises.

The firm has its headquarters in Irvine, California and was incorporated in 2014, on April 3rd by Tan Tran. It operates as part of the communication equipment industry, under the technology sector. The firm primarily serves consumers in Southeast Asia and Vietnam.

The company seeks to establish a strong foothold in the emerging and high-growth markets of Southeast Asia through impact-driven financial services targeting the underserved. With Vietnam as the focal starting point, its goal is to be a valuable financial partner for the SMEs throughout Southeast Asia, helping their business become borderless and together shaping the region into a global economic powerhouse of growing supply chains and manufacturing.

The enterprise, through its VoiceStep Telecom LLC wholly-owned subsidiary, offers a one-stop solution with regard to business-class Voice over Internet Protocol (VoIP) services to its small to medium-sized business customers in the United States. VoiceStep offers a cloud-based multi-location, multi-user, enterprise-grade communications solution that enables employees to communicate through voice, text, Web conferencing, and fax on devices, including smartphones, tablets, personal computers (PCs), and desk phones.

The firm remains committed to accelerating its neobanking strategy and developing impactful digital financial solutions for millions of SMEs in Southeast Asia and Vietnam, a move that may in turn encourage more investments into the firm.

Vemanti Group (VMNT), closed Thursday's trading session at $0.175, even for the day. The average volume for the last 3 months is 87,768 and the stock's 52-week low/high is $0.062/$0.375.

Caduceus Software Systems (CSOC)

Investor News Source, Penny Dreamers, OTCPicks, Pumps and Dumps, Penny Stocks VIP, Insane Stocks, Titan Stocks, PennyPic, Penny Stock Alley, KillerPennyStocks, Penny Stock Circle, Gladiator Stocks, Free Penny Alerts, Free Investment Report, Explicit Penny Picks, Monster Stox, VictoryStocks, Stockpicktrading, PennyStockClub, OTCtipReporter, Ox of Wallstreet, Penny Stock Pros, Stock Alerts, The Stock Scout, Actual Gains, Bull in Advantage, PennyStockScholar, PennyTrader Publisher, MyBestStockAlerts, Penny Stock Rumble, WallStreetBeats, StockLockandLoad, Growing Stocks Reports, Momentum Hunter,, StockRunway,, StockRockandRoll, Video Penny Stocks, Canadian Microcap Report, OTCReporter, QualityStocks, Research Driven Investor,,, InvestorSoup, Top Best Pennystocks, Investor News, TradeThesePicks,,,, BeatPennyStocks, Beacon Equity Research, ChartAdvisor, HotOTC, Epic Stock Picks, Crazy Carl, Damn Good Penny Picks, We Beat Wallstreet, BullRally, BUYINS.NET, CoolPennyStocks, Fast Moving Stocks, AlphaPennyStock, PennyInvest, StockHideout, StockEgg, Stockdigest Report, Stock Roach, Stock Preacher,, Smart Penny Stocks, SmallCapStockPlays, SimplyBestPennyStocks, RockingPennyStocks, RedChip, PickPennyStocks, PennyStockVille,, StockMister, Michael Stone, The Stock Analyzer, Nebula Stocks, OTC Advisors,,, The Ox of Wallstreet, StockRich, OTCSHUB, The Bull Report, Penny Picks, Wolf of Penny Stocks, Penny Stocks Finder, MadPennyStocks and Penny Stock Beats reported earlier on Caduceus Software Systems (CSOC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Caduceus Software Systems Corp (OTC: CSOC) is a holding firm that is focused on the acquisition and merger of commercialized businesses, as well as supplying quality, healthy, and innovative products and solutions.

The firm has its headquarters in Chino, California and was incorporated in 2006, on December 13th. Prior to its name change in March 2011, the firm was known as Bosco Holdings Inc. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm serves consumers around the world.

The company operates through its subsidiary, McLovin’s Pet Food Inc. Through its subsidiary, it manufactures and distributes pet food and accessories. Its pet food and pet care products include food, hygiene, toys, and other accessories. The company is also involved in the business of providing medical software to medical professionals. Its software offers patient management, patient appointment scheduling, physician memorandum recording, medical symptom and ailment recording and digital image recording. The company also offers a suite of medical management applications, collectively named Caduceus MMS, that focus on an alternative to traditional patient administration systems, reducing the time and expense involved in managing appointment scheduling, providing practitioners with a comprehensive set of resource, prescription and contraindication libraries, and a sophisticated architecture designed to minimize the billing submission time while maximizing the successfully reimbursements to the clinic.

The firm, through its whole-owned subsidiary, recently expanded its retail presence following its new partnership with major retailers, a move that will extend its consumer reach while also bringing in additional revenues into the firm.

Caduceus Software Systems (CSOC), closed Thursday's trading session at $0.0227, off by 1.3043%, on 38,300 volume. The average volume for the last 3 months is 1,844 and the stock's 52-week low/high is $0.0026/$0.0346.

PharmaChem (PCHM)

Stock Traders Chat and Real Pennies reported earlier on PharmaChem (PCHM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PharmaChem Inc. (OTC: PCHM) is a company engaged in the provision of integrated drug testing services.

The firm has its headquarters in Fort Worth, Texas and was incorporated in 1971. It operates as part of the diagnostics and research industry, under the healthcare sector. The firm serves consumers around the globe.

The enterprise primarily sells and distributes the PharmChek Sweat Patch Device (PharmChek). PharmChek is a system that uses sweat to detect the presence of illegal drugs. It comprises of a small absorbent pad, a transparent polyurethane outer covering and a release liner. PharmChek functions as a storage device where drugs are retained on the absorbent pad for detection in the laboratory. This system helps detect Marijuana, Opiates, Cocaine, Amphetamine, PCP, Methamphetamine, Fentanyl, Hydromorphone, Oxycodone, Hydrocodone and Oxymorphone. Its products include PharmChek Overlay, PharmChek Analysis Panels and PharmChek for the Workplace. The PharmChek Overlay is made of the same polyurethane film as the PharmChek Sweat Patch and can be used to extend the wear time of the PharmChek Sweat patch. The Sweat Patch technology is tamper-evident, cannot be diluted, substituted, or adulterated without detection, and is confirmed by LC/MS/MS for both parent drug and drug metabolite.The product is used in a number of industries, such as aerospace/aviation, oil and gas field and marine environments, manufacturing, mining, utilities and transportation.

The company remains committed to better meeting client needs and generating additional value for its shareholders.

PharmaChem (PCHM), closed Thursday's trading session at $2.62, even for the day. The average volume for the last 3 months is 579 and the stock's 52-week low/high is $1.2001/$3.20.

Kingsgate Consolidated (KSKGF)

We reported earlier on Kingsgate Consolidated (KSKGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kingsgate Consolidated Limited (OTC: KSKGF) (ASX: KCN) (FRA: KCN) is a mining and exploration firm focused on exploring for, developing and mining gold and silver mineral properties.

The firm has its headquarters in Sydney, Australia and was incorporated in 1970. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company’s operating segments include Chatree Gold Mine, Thailand, and Nueva Esperanza Gold/Silver Project, Chile. It generates the majority of its revenue from its Chatree Gold Mine project.

The enterprise and its Thai subsidiary, Akara Resources Public Company Ltd, own the Chatree Gold Mine (Chatree) in central Thailand. The Chatree project is located in central Thailand, about 280km north of Bangkok. Chatree’s operations have historically been a large-scale, low-grade, open-pit gold mine. It also holds 100% interest in an advanced development project known as Nueva Esperanza. This project is located in the highly prospective Maricunga Gold/Silver Belt in Chile. Nueva Esperanza is a silver and gold project comprising several well-defined deposits hosted in a high sulphidation epithermal (hydrothermal) system. The main deposits are Arqueros, Chimberos and Teterita. The Nueva Esperanza (New Hope) Project is located in the Maricunga Gold Belt of the Atacama Region of Northern Chile, roughly 140km north-east of the city of Copiapo, a regional mining center.

The firm remains committed to advancing its exploration efforts at its projects and generating additional value for its shareholders.

Kingsgate Consolidated (KSKGF), closed Thursday's trading session at $0.8198, even for the day. The average volume for the last 3 months is 29,415 and the stock's 52-week low/high is $0.7095/$1.39.

SideChannel (SDCH)

Stocks to Buy Now, SmallCapRelations, SeriousTraders, QualityStocks, MissionIR, InvestorBrandNetwork, Tiny Gems, StocksToBuyNow and reported earlier on SideChannel (SDCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SideChannel Inc. (OTCQB: SDCH) is a company engaged in the provision of cybersecurity, privacy and risk management solutions.

The firm has its headquarters in Worcester, Massachusetts and was incorporated in 1953, on June 22nd. Prior to its name change in July 2022, the firm was known as Cipherloc Corp. It operates as part of the software-infrastructure industry, under the technology sector. The firm mainly serves consumers in North America.

The company is committed to creating top-tier cybersecurity programs for mid-market firms to help them protect their assets.

The enterprise offers virtual chief information security officer (vCISO) services augmented by additional privacy management tools and capabilities. Its vCISO model provides companies access to C-suite level cybersecurity professionals. The enterprise’s product, RealCISO, is an intuitive software platform that helps companies of all sizes to understand and manage cyber risk. Its services include virtual CISO, virtual privacy officer, risk assessments, cybersecurity compliance, third party risk management, training and awareness, and team building and staffing. The enterprise deploys field-skilled, and experienced talent to harden organizations defenses against cybercrime. It provides cybersecurity, talent, and software tools with a focus on clients in the robust and growing middle market. It serves various industries, including finance, healthcare (tech), life sciences, legal and energy as well as research institutes.

The firm recently announced its latest financial results, which show considerable growth in its revenues. It remains committed to successfully executing its strategy and better meeting the evolving needs of its clients. This may in turn help create value for its shareholders and bolster its overall growth.

SideChannel (SDCH), closed Thursday's trading session at $0.07295, up 23.6441%, on 169 volume. The average volume for the last 3 months is 625,671 and the stock's 52-week low/high is $0.0402/$0.1776.

Curaleaf Holdings Inc. (CURLF)

InvestorPlace, Kiplinger Today, MarketBeat, Daily Trade Alert, Top Pros' Top Picks, Cabot Wealth, Profit Trends, MarketClub Analysis, QualityStocks, StreetInsider, The Online Investor, Wealth Insider Alert, The Street, Trades Of The Day, Trading For Keeps, Early Bird, StreetAuthority Daily, wyatt research newsletter, TradersPro, Investment U, Wyatt Investment Research, Daily Profit, CFN Media Group and Schaeffer's reported earlier on Curaleaf Holdings Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The California Assembly has approved a bill to legalize marijuana cafes in the state; the body sent the bill to Governor Gavin Newsom’s desk for his signature. Bill AB 374 would allow recreational cannabis dispensaries to provide customers with noncannabis drinks and foods as long as they receive approval from local authorities.

Senate lawmakers received the measure from assemblymembers, made slight amendments, and approved it in a 33 to 3 vote nearly one week ago before sending it back to the assembly for a concurrence vote. The assembly voted in favor of the amended cannabis cafe bill just a few days after receiving it from the Senate in a 48 to 7 vote, putting it on track to becoming a law if it receives Governor Newsom’s signature.

Assemblymember Matt Haney introduced the measure and envisioned it going through a relatively quick concurrence vote due to “strong bipartisan support.”

While lawmakers in the state recently concluded working on marijuana cafe legislation, California has a grey market populated with businesses that found legal workarounds to provide cannabis for on-site consumption while providing food for guests. If Newsom signs the measure into law, entrepreneurs with authorization from local governments will be able to prepare and sell nonmarijuana soft drinks and foods to customers at retail establishments.

Haney’s bill would legitimize the industry while prohibiting smoking tobacco and the sale of alcoholic beverages at marijuana cafes. It would also allow cannabis lounges to hold live performances of different varieties and sell tickets to these events.

Although microbusinesses and retailers would have the authority to sell freshly prepared drinks and foods, only retailers would be allowed to sell prepackaged food to customers, keeping the cannabis cafe rules in line with policies adopted by the California Department of Cannabis Control (DCC) in late 2022. Senate lawmakers amended the cannabis cafe bill to make it clear that it prohibits the sale of hemp-based foods and drinks at marijuana cafes by clarifying that it does not consider such products to be “noncannabis” products. The measure also states that cannabis cafes should store and display noncannabis items separately and distinctly from any cannabis products on site.

California legalized recreational cannabis in late 2016 and quickly built up the largest recreational marijuana market in the world. Cannabis retailers in the state generate billions of dollars in revenue every year, and even though marijuana sales declined last year, California‘s cannabis market had a $2.2 billion valuation in 2022.

The regulatory change allowing cannabis cafes to operate in California is likely to be copied in other jurisdictions where marijuana is legal for adult use. As a result, companies such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) could find themselves having to adjust to this reality in the markets where they operate.

Curaleaf Holdings Inc. (CURLF), closed Thursday's trading session at $4.05, off by 10.793%, on 1,350,908 volume. The average volume for the last 3 months is 863,668 and the stock's 52-week low/high is $2.19/$7.90.

atai Life Sciences N.V. (ATAI)

QualityStocks, MarketBeat, The Online Investor, StockMarketWatch, StreetInsider, Dynamic Wealth Report, Uncommon Wisdom,, MarketClub Analysis, BestOtc, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick, InsiderTrades, PennyOmega, PennyToBuck, Schaeffer's, Small Caps, StockHotTips, TraderPower, Awareness Stocks, StockOodles, Street Insider, The Street, TopPennyStockMovers and ProTrader reported earlier on atai Life Sciences N.V. (ATAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

This June, America’s first-ever service center for psilocybin-assisted therapy opened in Oregon, marking both the state and country’s first definitive steps toward legalizing therapeutic psilocybin for the masses. Oregon is the first state in the country to offer psilocybin-related treatments; the state went a step further in June by opening the first center where eligible adults could experience guided psilocybin trips.

Epic Healing Eugene will give Oregonians aged 21 years and older the opportunity to experience guided psychedelic trips for around six hours without the need for referrals or prescriptions. The center currently has more than 3,000 people on its waitlist and will likely attract more customers as time passes.

Psilocybin is the main hallucinogenic element in magic mushrooms and it has exhibited significant potential as a treatment for mental disorders such as depression, anxiety and post-traumatic stress disorder (PTSD) in a growing number of studies. A recent surge in psychedelic research found that psilocybin and a variety of other psychedelics have potent mental-health benefits and could function as alternative mental-health treatments, leading to an explosion in interest among the mainstream public and pharmaceutical firms.

Lawmakers across the country are now considering the possibility of legalizing therapeutic psychedelic use based on studies painting hallucinogens as potentially safer and more effective alternatives to conventional mental-health treatments.

Psychedelic reform proponents hope the efforts to legalize hallucinogens in Oregon could trigger a mental health care revolution. Experts estimate that close to 50% of Americans suffering from mental disorders do not obtain the treatment they need, even though 47% of U.S. adults report experiencing anxiety while 39% report depression symptoms.

Those who do seek treatment for their mental ailments often have to deal with short- and long-term side effects such as sexual dysfunction, diabetes, headaches, serotonin syndrome, gastrointestinal bleeding, mania or hypomania, blood disorders, liver disorders, metabolic syndrome and seizures. Psychedelics have proven in numerous studies that they can alleviate numerous mental-health symptoms over the long-term with fewer side effects and at lower doses.

With states such as Oregon and Colorado taking to psychedelics in a major way, a wave of psychedelic reform may just sweep over the United States, resulting in the launch of dozens of state-legal psychedelic sectors. Voters in Colorado approved a measure to legalize the use of psilocybin, and the California Legislature recently advanced a bill that would legalize the possession and consumption of certain psychedelic plants.

The Oregon Psilocybin Services Section, which regulates Oregon’s fledgling psychedelic industry, says it has received hundreds of thousands of inquiries from across the globe about the specifics and potential benefits of a regulated therapeutic psychedelic industry.

The positive response that the Oregon psilocybin program is garnering is an encouragement to psychedelic drug-development companies such as atai Life Sciences N.V. (NASDAQ: ATAI), which seek to address the demand for new treatments for mental-health disorders.

atai Life Sciences N.V. (ATAI), closed Thursday's trading session at $1.31, off by 3.6765%, on 692,845 volume. The average volume for the last 3 months is 2.628M and the stock's 52-week low/high is $1.14/$3.70.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, The Street, MarketBeat, StocksEarning, Daily Trade Alert, Trades Of The Day, Wealth Insider Alert, The Online Investor, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, BUYINS.NET, Zacks, StockEarnings, The Wealth Report, QualityStocks, Top Pros' Top Picks, Investopedia, Stock Up Featured, InvestmentHouse, Cabot Wealth, Daily Profit, Early Bird, InsiderTrades, Jim Cramer, The Rich Investor, Small Cap Firm, 24/7 Trader, Stock Gumshoe, InvestorsUnderground, InvestorsObserver Team, VectorVest, TheTradingReport, Wall Street Window and Money Morning reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Minnesota Supreme Court has established that the mere presence of a cannabis scent does not, by itself, provide sufficient grounds for law enforcement officers to conduct a vehicle search. The ruling stemmed from an incident that occurred during a traffic stop in Meeker County in 2021 when Adam Torgerson found himself being pulled over by Litchfield police for excessive auxiliary lights on his car’s grill.

During the stop, one of the officers claimed that they could detect the scent of marijuana emanating from the open car window. Torgerson, accompanied by his wife and a child, vehemently denied the presence of marijuana in the vehicle. Another officer subsequently approached the scene, also claiming to detect a marijuana scent. The officers instructed everyone to exit the vehicle and proceeded to conduct a search, finding small quantities of methamphetamine and paraphernalia.

Torgerson was not driving in an erratic manner, and there was no observable evidence of criminal activity in plain sight when the officers approached the vehicle. The officers’ rationale for establishing probable cause was solely anchored in the detection of cannabis odor.

Subsequently, a district court rendered a verdict deeming the evidence obtained during the search inadmissible. At the time (2021), there existed certain contexts in which the possession of marijuana was lawful; hemp, which bears a striking resemblance to regular marijuana in both appearance and odor, and medical cannabis were legal. Moreover, the possession of limited quantities of marijuana had been decriminalized by that juncture, still considered unlawful by statute but not inherently constituting a crime.

The state of Minnesota contested this decision, pursuing an appeal that was ultimately unsuccessful. The case then ascended to the Supreme Court, which upheld the preceding decisions made by lower courts. This judgment aligns with Colorado’s legal stance, where, since 2016, the scent of marijuana alone has not constituted an adequate probable cause for conducting a vehicle search.

However, the Minnesota ruling does not address any potential changes that may have transpired following the statewide legalization of low-dose THC edibles in 2022 and the subsequent legalization of recreational cannabis this year.

In any case, this verdict stands as a triumph for advocates of civil liberties and proponents of racial justice, who have persistently contended that the detection of marijuana scent has often been utilized as a pretext for unconstitutional searches, thereby infringing upon Fourth Amendment rights.

There are many other subtle and not-so-subtle remnants of marijuana prohibition-era restrictions that still exist in different states and jurisdictions. With these types of rulings, the cannabis industry, including companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), may look forward to the complete end to those residual forms of prohibition.

Cronos Group Inc. (CRON), closed Thursday's trading session at $2.12, off by 2.7523%, on 2,584,236 volume. The average volume for the last 3 months is 20,980 and the stock's 52-week low/high is $1.64/$3.616.

Breezer Ventures Inc. (BRZV)

PennyStocks24, Actual Gains,, BestStocksDaily,, StockRockandRoll, Fortune Stock Alerts, ResearchOTC, PennyPickAlerts, QualityStocks, PennyStockClub, Penny Stock Circle, 1-2-3 Stock Alerts, Pumps and Dumps,, Greenbackers, Penny Stocks Finder, Penny Stock Rumble, Penny Stock Pros, YourStockReports, Stockoutlaws, ActiveMarketReport, AwesomePennyPicks, Trading Desk, The Stock Scout, ExclusiveStockAlerts,, StockHideout, StockGuru, Stock Roach, Blaque Capital Stocks, Fast Moving Stocks, Beacon Equity Research, Crazy Carl, Email Stock Picks, AddictivePennyStocks, JackpotStock Picks, Hot Stock Profits, HotStockProfits, Bird Gang Stocks, Stock Edge, Xtreme Stock Picks, WallstreetSurfers, Wallstreetbuzz, Value Penny Stocks, TheLightningPicks, Streetwise Reports, StockMister, PennyStock MarketBulls, Stock Preacher, Jet-Life Penny Stocks, SmallCapStockPlays, RockingPennyStocks, RagingStock Bull, PennyStock PayCheck, Pastor Phil, OtcWizard, MyBestStockAlerts, marketwirepress and Stock Trader reported earlier on Breezer Ventures Inc. (BRZV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Breezer Ventures (OTC: BRZV) and its wholly owned subsidiary, Magnum Finest Spirits Inc., have begun commercial production of its proprietary Magnum 1770 Gin; the new offering joins the company’s current lineup of Exceptional Bourbon, Ultra Premium Vodka, a wildly popular Lemonade, and Flavored Spirits. According to the announcement, the new gin offering was developed with the skilled guidance of Magnum’s master distiller partners, Kalifornia Distilleries Inc. Based on a centuries-old family recipe, Magnum 1770 Gin is distinguished by juniper combined with a unique blend of botanicals, giving the beverage a smooth finish and luxurious taste. Magnum 1770 Gin will be available in three formats: an ecoconscious 1.75-liter Bag in a Box and two stylish-square bottles, one 750 ml and 1.75 liter. Production of the new gin began in Q4 2024 with product available on the shelves of big-box wholesale outlets, grocery stores, and trending bars and restaurants starting in Southern California, then Las Vegas and other Nevada cities, and then expanding throughout the country.

“Our Magnum 1770 Gin has been developed over a 300-year period and recently perfected by our partner master distillers at Kalifornia Distilleries in Murrieta, located in Southern California,” said Breezer Ventures CEO Freddy Figueroa in the press release. “Through extensive testing, research and sampling, our gin has been enthusiastically received by industry heavyweights, distributors, bar and restaurant/business owners, and random sample groups alike. We are excited to launch our first exclusive products, as promised, ahead of schedule. We believe Magnum 1770 Gin will be an esteemed choice and sought after by a broad range of enthusiasts to gin aficionados.”

To view the full press release, visit

About Breezer Ventures Inc./Magnum Finest Spirits Inc..

Magnum is a distilled spirits and marketing company offering products with a centuries-long history of outstanding quality. What separates Magnum from the pack is functionally innovative and environmentally conscious packaging, using its Bag in a Box (“BiB”) technology, and distinctive billboard-style labeling. Never to be associated with discount or bulk, top-shelf Magnum 1770-branded products include an exceptional Bourbon, premium Vodka and an esteemed Gin, its wildly popular Lemonade, as well as trending Flavored Spirits. The company plans to expand on its relationships with the big box wine and liquor stores, warehouse liquor emporiums, traditional liquor stores, VIP and trending restaurants, bars and nightclubs. For more information about this company, please visit

Breezer Ventures Inc. (BRZV), closed Thursday's trading session at $0.055, up 3.7736%, on 23,000 volume. The average volume for the last 3 months is 990,009 and the stock's 52-week low/high is $0.013/$0.17.

The QualityStocks Company Corner

Renovaro BioSciences Inc. (NASDAQ: RENB)

The QualityStocks Daily Newsletter would like to spotlight Renovaro BioSciences Inc. (NASDAQ: RENB) .

IBN, a multifaceted financial news and publishing company for private and public entities, has announced, through its biotech and biomed brand BioMedWire, the recent private placement offering for NanoVibronix (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave ("SAW") Portable Ultrasonic Therapeutic Devices. NanoVibronix in late August entered into definitive agreements for the purchase and sale of an aggregate of 2,906,977 shares of its common stock (or common stock equivalents in lieu thereof), series A-1 warrants to purchase up to 2,906,977 shares of common stock and series A-2 warrants to purchase up to 2,906,977 shares of common stock, at a purchase price of $1.72 per share of common stock (or common stock equivalent in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. NanoVibronix intends to use net proceeds (from the expected $5 million in gross proceeds from the offering) for general corporate purposes, including funding of its development programs, commercial planning and sales and marketing expenses, potential strategic acquisitions, general and administrative expenses and working capital.

BioMedWire ("BMW") is running on HOT with a winner like Renovaro BioSciences Inc. (NASDAQ: RENB). The company has climbed from $0.50 in July to $3.80 and is trading over $95,000,000 since starting with IBN and is being featured on the Circle of Champions today.

To view the full press release, visit

Renovaro BioSciences Inc. (NASDAQ: RENB), formerly Enochian BioSciences Inc., is an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy. The company aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers, and to potentially treat or cure serious infectious diseases such as Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) infection.

The oncology platform is now at the forefront of Renovaro’s development activities. While Renovaro’s current efforts focus primarily on pancreatic cancer, it plans to include other solid tumors with short life-expectancy in the first in human Phase I/IIa studies that are on track to start by mid-2024. The company’s Pre-Investigational New Drug (pre-IND) submission included a human study plan covering pancreatic cancer, as well as other cancers that are difficult to treat, potentially including triple-negative breast cancer, head and neck cancers and mesothelioma.

Renovaro’s proprietary, novel technology uses cell- and gene-therapy to promote a renewed immune response against solid tumors. Important confirmatory results from two humanized mouse models using the company’s novel dendritic cell-based therapy, independently conducted by Dr. Anahid Jewett, a renowned cancer researcher in the field of immunotherapy at UCLA, were presented previously at two scientific conferences and were the foundation supporting a pre-IND submission to the U.S. Food and Drug Administration. Notably, Dr. Jewett’s findings from these studies consistently demonstrated 80% to 90% pancreatic tumor reduction in size and weight that was correlated with significant enhancement of key aspects of the immune response.

Renovaro is headquartered in Los Angeles, California.


Renovaro’s product development strategy is anchored in the use of “non-self” or allogeneic cells that enhance targeted immune response. Its lead candidate, RENB-DC11, is an innovative therapeutic vaccination platform that could potentially be used to induce life-long remissions from some of the deadliest solid tumors.
Treatment with RENB-DC11 has now been shown to significantly reduce the size of human pancreatic tumors in humanized mice in three independent studies. The reduction in tumor size correlated with statistically significant increases in key components of an immune response.

Pre-IND was completed in June 2023, with IND filing forecast for first half of 2024. First in-human Phase I/IIa trials are predicted shortly after in H1 of 2024, including pancreatic and other solid tumors with poor treatment options and life-expectancy.

Renovaro believes that RENB-DC11 could represent the most promising and effective strategy to achieve life-long remission for a number of common and deadly tumors.

Other Development Candidates

In addition to its lead oncology platform, Renovaro’s development pipeline includes a platform targeting infectious diseases, including:

  • RENB-HV12 – An engineered allogeneic T-Cell vaccine, this therapeutic HIV vaccine candidate enhances immune infiltration, immune killing and immune surveillance. Potential pre-IND submission is planned for first half of 2024, with IND-submission expected in second half of 2024.
  • RENB-HV21 – Leveraging allogeneic NK plus Gamma Delta T (GDT) cells as potential therapy for HIV, ENOB-HV21 shows promising preliminary results without confounding factors. Renovaro owns an exclusive license and has completed the Pre-IND submission, with a potential IND submission and human trials expected in 2024.
  • RENB-HV01 – Caring Cross, a non-profit corporation, has shown that its proprietary CAR-T cells cure HIV in a mouse model. Studies in humans have begun. Renovaro has entered into a profit-sharing sublicense with Caring Cross and would share in profits if the product is commercialized.
  • RENB-HB01 – This therapeutic approach aims to eliminate all HBV rapidly (“seek and kill”) with a two to three dose treatment regimen. It is expected to be applicable for early disease to maximize impact with low risk of toxicity. Pre-IND comments have been received from the FDA for its AAV-delivery system.
    LOI to Merge with GEDi Cube International Ltd.

On August 9, 2023, Renovaro announced its execution of a binding, exclusive letter of intent to merge a subsidiary with cutting-edge health AI company GEDi Cube International Ltd. The combined company is expected to create a potential multiplier effect to accelerate earlier diagnosis, more effective therapy, and precision in silico drug discovery.

GEDi Cube’s innovative technology, developed over nearly a decade, has already validated earlier diagnoses of lung cancer in humans at a leading university hospital. GEDi Cube has likewise created the early diagnosis technology for 12 additional cancers, including pancreatic and breast cancer.

“I believe joining forces with GEDi Cube could enhance the efficacy of our upcoming trials and speed up the discovery of novel treatment approaches, thereby extending our life-saving technology to more cancer patients and renewing hope for them and their families,” Dr. Mark Dybul, CEO of Renovaro, stated in the news release.

GEDi Cube is led by CEO Craig Rhodes, who brings to that company tremendous industry experience leading life sciences groups at industry leaders Intel, Oracle and NVIDIA.

Market Opportunity

Pancreatic cancer alone is diagnosed globally in approximately 495,000 people each year, including roughly 64,000 in the U.S. Nearly 466,000 of those patients die annually, including approximately 51,000 in the U.S. Because of limited treatment options, life expectancy is very poor – with an approximately 10% patient survival rate at five years after diagnosis.

The global pancreatic cancer treatment market was valued at $2.15 billion in 2021 and is projected to grow from $2.48 billion in 2022 to $6.85 billion by 2029, according to Fortune Business Insights. That growth represents a CAGR of 15.7% for the forecast period.

A separate report from Fortune Business Insights projects that the global HIV drug market will grow from $30.46 billion in 2021 to $45.58 billion in 2028, recording a CAGR of 5.9% over the forecast period.

According to GlobalData, the value of the market for hepatitis B treatment is forecast to experience a significant increase in the coming years, with revenues expected to grow from $1.6 billion in 2022 to $10.5 billion in 2029. That represents a very rapid CAGR of 30% over the period. An estimated 296 million people suffer from the condition worldwide.

Management Team

Dr. Mark Dybul is the CEO of Renovaro. He has served as a tenured professor in the Department of Medicine at Georgetown University Medical Center since June 2017. He also served as Faculty Co-Director of the Center for Global Health and Quality from 2017-2021. Dr. Dybul has worked on HIV and public health for nearly 30 years as a clinician, scientist, teacher and administrator, including as an architect and eventually the Global Ambassador of the U.S. President’s Emergency Plan for AIDS Relief and the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria from 2013 through May of 2017, and as the co-director of the Global Health Law Program at the O’Neill Institute for National and Global Health Law from 2009 through 2012. He is a member of the U.S. National Academy of Medicine.

Luisa Puche is the company’s CFO. She has served as a senior accounting and financial advisor and president of Puche Group LLC from 2015-2019. She served in various key executive roles, including Interim Chief Accounting Officer, at Brightstar Corp., a $10 billion global wireless device services provider. Ms. Puche began her career at Ernst & Young, where she served for approximately 10 years. Leveraging her broad global audit, advisory and corporate expertise, she has provided strong cross-functional leadership experience managing small and large projects for both publicly traded and privately held companies in various industries, including a global implementation of the latest revenue recognition accounting standard for Del Monte, as well as the global implementation of their SOX-404 program.

Francois Binette, Ph.D., is the Chief Operating Officer and Executive Vice President of Research & Development at Renovaro. He has over 25 years of product development expertise in Advanced Therapies and Regenerative Medicine. His broad industry experience spans a wide range of serious medical conditions, from orthopedics to ophthalmology, CNS and immuno-oncology. His career includes positions at Genzyme, Biosyntech, the DePuy Franchise of Johnson and Johnson, Medtronic and Lineage Cell Therapeutics. He received his Ph.D. from Laval University in Québec, followed by post-doctoral training at the Sanford-Burnham Institute in La Jolla and Harvard Medical School in Boston.

Renovaro BioSciences Inc. (NASDAQ: RENB), closed Thursday's trading session at $3.85, up 13.5693%, on 543,617 volume. The average volume for the last 3 months is 89,412 and the stock's 52-week low/high is $0.3928/$3.87.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria's IND application builds on five previous human clinical studies showing zero serious adverse effects and evidencing a reduction in resting blood pressure in test subjects

DehydraTECH(TM)-CBD has the potential to have pronounced clinical benefits relative to the available anti-hypertensive therapeutics on the market today

Work mostly under Lexaria's control was completed earlier this year, including the batch manufacturing of DehydraTECH-CBD and placebo materials necessary for the IND application

Lexaria is waiting to submit until the necessary documentation outside of their control is ready for the IND application

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its intention to launch new human and animal studies to examine DehydraTECH(TM)-processed glucagon-like peptide-1 ("GLP-1") drugs such as, but not limited to, semaglutide sold under Novo Nordisk's brand names Ozempic(R), Wegovy(R) and Rybelsus(R), for purposes of improved  bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. According to the update, Lexaria, through these studies, hopes to achieve superior pharmacokinetic ("PK") performance using DehydraTECH-powered GLP-1 drugs, which could enable drug delivery via oral capsule at lower costs than current injectables, with reduced side effects and enhanced health benefits. This is a significant expansion of Lexaria's ongoing study program to examine its patented DehydraTECH-CBD for diabetes control in humans. The company now intends to evaluate this alongside and together with DehydraTECH-processed GLP-1 agents. Program design has commenced, and initial study work will begin soon.

To view the full press release, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Thursday's trading session at $0.92, up 1.6912%, on 25,292 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.87/$.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company focused on rare- and critical-metal resources, extraction, beneficiation and separation technologies with the potential for production, growth and scalability, has completed the local approval process of the Industrial Tax Exemption Program ("ITEP") for its planned 80,800 square-foot brownfield facility located Alexandria, Louisiana. The company will use the location as its Louisiana Strategic Metals Complex ("LA-SMC") rare earth element ("REE") separation and oxide production facility. The company has obtained approvals from the Louisiana Board of Commerce and Industry as well as the Rapides Parish's police jury, school board and sheriff's office. According to the announcement, the company's commitment to creating 100 family-wage paying jobs along with its planned capital investment of $75 million and a statewide baseline of employees from which new jobs at the facility will be counted were key factors in obtaining the exemption. Ucore plans production ramp-up from 2,000 tonnes per annum (ex-cerium and ex-yttrium) of total rare earth oxide in first quarter 2025 to 5,000 in 2026 and reaching 7,500 by 2027.

"Ucore is extremely grateful to Louisiana Economic Development, the C&I board, the Rapides Parish's police jury, school board and sheriff's office for their support in granting the ITEP approvals to date required to advance our LA-SMC project in Alexandria, Louisiana," said Ucore vice president and COO Mike Schrider in the press release. "The overall state and local support we are receiving for the establishment of one of the first modern rare earth element processing facilities in North America has been an amazing experience, and we are diligently working to execute a Louisiana project that has the potential to significantly enhance the manufacturing landscape across North America as the world shifts to electrification."

To view the full press release, visit

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX™, for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.


Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Thursday's trading session at $0.5875, up 5.3812%, on 33,300 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.48/$1.15.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announced that the New York Power Authority ("NYPA") has purchased the company's campus delivery cargo vans after successful completion of an EV pilot program at NYPA's 16-turbine hydroelectric facility in northern New York. According to the update, the 60-day EV cargo van pilot began on July  6, 2023, and concluded in early September 2023. As a result, NYPA will purchase the initial pilot vehicles for fleet operations at its St. Lawrence-Franklin D. Roosevelt Power Project and is assessing additional NYPA locations for Mullen's full lineup of commercial EVs. "It's great to see our EVs enter the Northeast market with the New York Power Authority, our nation's largest public utility, using our delivery utility model for campus transportation," said David Michery, CEO and chairman of Mullen Automotive. "Our EV cargo van is a perfect fit for large, closed workplace campus scenarios."

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Thursday's trading session at $0.5616, up 2.1091%, on 42,442,299 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3901/$137.25.

Recent News

Near Intelligence Inc. (NASDAQ: NIR)

The QualityStocks Daily Newsletter would like to spotlight Near Intelligence Inc. (NASDAQ: NIR).

Near Intelligence (NASDAQ: NIR) is a global data intelligence platform that curates one of the world's largest sources of intelligence on people and places. The company today announced its positioning as a trusted partner of leading global commercial real estate ("CRE") companies seeking high-quality real estate analytics on any location, building or site. Representing a combined annual revenue of nearly $87 billion and over $200 billion in assets under management, the world's leading CRE companies rely on Near to drive data-driven business decisions and enhance strategies as the industry adapts to rapidly evolving consumer trends. "Near's data insights allow me to conduct site evaluations using near real-time, robust and great quality data," said John McClelland, VP of research at Coldwell Banker. "The intuitive charts, maps and searchable historical data establish me as a market leader and adopter of cutting-edge technology. In today's landscape, one cannot ask a client to solely trust a hunch, but with Near's data, I am able to validate my decades of experience, build a winning case, and develop deeper partnerships with my clients."

To view the full press release, visit

Near Intelligence Inc. (NASDAQ: NIR), a global Data Intelligence Platform, curates one of the world’s largest sources of intelligence on people and places. Near’s patented technology analyzes data to deliver insights on approximately 1.6 billion unique user IDs across 70 million points of interest in more than 44 countries. With Near’s three-pillared approach – high-quality data, privacy, and AI – operational and marketing leaders are empowered with solutions to successfully engage and grow their businesses at scale. With a presence in Pasadena, San Francisco, Paris, Bangalore, Singapore, Sydney, and Tokyo, Near serves enterprises in diverse industries, including retail, real estate, restaurants, travel/tourism, telecom, media, and more.

Established in 2012, Near employs vast data volumes to comprehend consumer behavior across digital and physical realms, ensuring privacy compliance through anonymization and aggregation. The company analyzes behavior around visited places and connected devices.

Near is headquartered in Pasadena, California.

Platform and Services

The Near platform delivers global, high-quality data in a privacy-safe environment, evaluating consumer activity across physical and digital spaces to provide business leaders with deep insights into the places their customers frequent, along with their brand and competitor preferences.
It is built on three fundamental tenets:

  • Global, High-Quality Data: The Near Platform provides high-quality insights about people and places from diverse industries and applications. Through complex data refinement processes, Near converts raw data into powerful insights that empower decision-makers with actionable information.
  • Privacy and Transparency: Data privacy and transparency are deeply ingrained in Near’s foundation. The platform is built on the principle of privacy by design, ensuring that data privacy considerations are integrated into every aspect of its products, processes, and practices. The Near approach empowers business decision-makers with control over their information and adheres to the most stringent global privacy regulations.
  • Data Science and AI Innovation: The Near Platform employs advanced algorithms and machine learning models to deliver high-quality insights, so users can decipher complex consumer behavior patterns and trends.

In August 2023, Near illustrated the value of its intelligence platform in one such industry – quick-service restaurants (QSRs). Many of the world’s largest QSR brands count Near as a trusted partner for high-quality data insights and restaurant analytics. By harnessing Near’s advanced analytics capabilities, top QSRs with combined annual revenues approaching $90B are able to understand consumer movement and behavior patterns, brand affinities, trade areas, and trends.

The company also collaborates with partners to strengthen their datasets by integrating Near’s physical and digital world understanding. Near’s data is always delivered with a privacy-first, consent-led approach via its SaaS-based geospatial analytics platform.

Market Outlook

An analysis from Fortune Business Insights estimated the global business intelligence market was valued at $27.11 billion in 2022 and is projected to grow from $29.42 billion in 2023 to $54.27 billion by 2030, a CAGR of 9.1% during the forecast period.

According to the report, global market growth can be attributed to the increasing adoption of cloud-based Artificial Intelligence/Machine Learning services and data analytics across organizations. A surge in demand for flexible architectures and adaptable solutions opens up market expansion opportunities.

Management Team

Anil Mathews is the CEO of Near. He is a visionary who has spent the past 22 years as a serial entrepreneur, building successful businesses around engineering, messaging, and social. He is passionate about creating new market companies with a strategic vision and technology capability that can provide substantial growth. He is also an advisor and investor to numerous startups across the globe.

Shobhit Shukla is President of Near. He currently runs the company’s global business and strategic initiatives, where he is responsible for executing Near’s vision to become the most accurate and privacy-safe source of intelligence on people and places. He holds an MBA from the Indian Institute of Management and advises multiple early-stage startups on growth strategy.

Gladys Kong is COO of Near. She was previously CEO of UberMedia, a data intelligence company acquired by Near. She was also CEO of Go Interactive, a fantasy sports company. Before that, she held Engineering and R&D vice president positions at and Idea Lab. She has a bachelor’s degree in engineering and applied science from Caltech and a master’s degree in computer science from UCLA.

Rahul Agarwal is the CFO of Near. He began his career at PwC India and later held accounting and finance roles at HT Media and InMobi, where he rose to the position of Head of Finance, North America. He is a graduate of The Institute of Chartered Accountants of India and holds an MBA in finance and strategy from the Indian Institute of Management at Bangalore.

Near Intelligence Inc. (NASDAQ: NIR), closed Thursday's trading session at $0.2937, up 40.5263%, on 36,988,227 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.19/$18.65.

Recent News

Electronic Servitor Publication Network Inc. (OTCQB: XESP)

The QualityStocks Daily Newsletter would like to spotlight Electronic Servitor Publication Network Inc. (OTCQB: XESP).

Electronic Servitor Publication Network (OTC: XESP) is a digital engagement company and a market disruptor offering cutting-edge data analysis and intelligent technology to help enterprises reach their target markets. "Through its managed service, which offers digital activation and engagement solutions, the company looks to provide superior intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, all tested avenues for elevating customer experiences and response. XESP is focused on the use of evolving technologies to increase customer reach and spur organizational growth. The company's proprietary technology, the Digital Engagement Engine(TM), is an example of its focus on solutions that directly address clients' digital engagement needs," a recent article reads. "By utilizing a combination of automation, unique data management, and a modern workflow built on a microservices architecture, XESP can offer what no competitor provides in the market. The company has differentiated itself through this technology, offering a unique value proposition."

To view the full article, visit

Electronic Servitor Publication Network Inc. (OTCQB: XESP) is a digital engagement company offering a managed service which provides digital activation and engagement solutions to companies that seek to optimize their growth. Its managed service is powered by a proven, proprietary technology – the Digital Engagement Engine™. This technology provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action – driving growth.

Electronic Servitor Publication Network’s services are designed to drive growth for both established and developing organizations. Through the optimization of digital interactions within current and new communities, the Digital Engagement Engine™ ensures that client content is relevant, reaches the right audience, and connects with the intended person at the right time.

The company calls it ‘Growth as a Service’.

Client implementation is nearly effortless, since the solution is completely managed by the Electronic Servitor Publication Network team. This business model allows clients to focus on their brands, core product offerings, and content creation, while the company manages the technology and outcome.

The company is headquartered in Minneapolis, Minnesota.


Electronic Servitor Publication Network’s Digital Engagement Engine™ utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift. Using sophisticated data analysis and smart technology, the Digital Engagement Engine™ provides companies with the ability to maintain complete control of their content while creating meaningful relationships with new customers and revenue streams.

The Digital Engagement Engine™ isn’t just another marketing or technology tool; it’s a way to develop real connections with target markets.

Market Outlook

According to a report by, an award-winning market research firm, the global customer engagement solutions market was estimated at $19.3 billion in 2022 and is forecast to grow to $32.2 billion by 2027, achieving a CAGR of 10.8% during the forecast period.

The report notes that these engagement solutions are vital to companies seeking to widen their customer bases, reduce customer churn rates and increase customer retention. These perceived benefits of customer engagement solutions are likely to drive their growing adoption around the globe during the forecast period, according to the report.

Management Team

Peter Hager is President and CEO of Electronic Servitor. He joined the company from Pointward Inc., a medtech customer engagement agency that provided solutions to drive market entry, growth, and commercialization for Fortune 500 health care brands and medtech startups. He has founded and managed multiple technology, professional services and medtech organizations throughout his career. Mr. Hager holds a bachelor’s degree from Macalester College in St. Paul, Minnesota, with concentrations in economics and psychology.

Jim Kellogg is CFO of Electronic Servitor. He has served as the principal of J. Kellogg & Company Inc., a business and tax consultant, since 2005. He has provided legal support to clients’ business valuations, business interruption and divorce property valuations. He has worked as a professional tax adviser since 1983. Mr. Kellogg obtained his JD with emphasis on taxation from Western State University College of Law and was certified as a financial planner by the College for Financial Planning in 1990.

Thomas (Denny) Spruce, RPh, is COO of Electronic Servitor. He oversees company infrastructure, regulatory reporting, and strategic partner relationships, among other roles and responsibilities. He joined the company in March 2022 and, since that time, has implemented foundational support processes, developed contractual relationships with service providers, managed financial and regulatory reporting and overseen contract development and management with the legal team. Mr. Spruce obtained a BS in Pharmacy from the University of Arkansas.

Electronic Servitor Publication Network Inc. (XESP), closed Thursday's trading session at $0.065, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.03/$0.16.

Recent News


The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

E-commerce accounted for close to 19% of global retail sales in 2022 and was projected to reach a valuation of $5.5 trillion in sales by the end of the year. With tens of millions of e-commerce businesses competing to attract the billions of customers who purchase products online every year, you will need an inspired strategy to stand out from the pack and build an identifiable brand. Lessons learned from this year should inform your decision-making process as you move into 2024. Review data from this year's campaigns and reports to see if you can glean any insights or spot any missing data. Additionally, make sure you adjust your reporting to Google Analytics 4 and inform your stakeholders of any changes that may arise due to the new data tracking system. Use a bigger data set to test new ideas and learn about consumer trends. Holiday seasons, for instance, often see a surge in e-commerce site traffic that can allow you to test improvements of optimizations specific to certain holidays. Platforms such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) are setting the pace with regard to revolutionizing how sellers and consumers benefit from the reach that e-commerce can give businesses engaged in various industries, such as healthcare.

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Thursday's trading session at $1.71, off by 10.9375%, on 12,777 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.2115/$4.26.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things ("IoT"), and cybersecurity sectors, has secured a new national program with the government of Finland. According to the announcement, the project will include the following PureSecurity offerings: PureProtect, PureTrack, PureTag, and PureMonitor. The program calls for SuperCom to deploy its Domestic Violence Monitoring Solution, an integral component of its PureSecurity Electronic Monitoring ("EM") Suite. These monitoring solutions will provide Finnish authorities with near real-time information, enabling them to ensure the safety of victims and enforce court-mandated restrictions. The company anticipates deploying the program in Q4 2023 and seeing recurring revenue begin that same quarter.

"We are delighted to secure another program for our innovative domestic violence solution, this time in Finland," said SuperCom president and CEO Ordan Trabelsi in the press release. "This achievement follows our successful deployment of other monitoring solutions for inmates and individuals on probation in Finland, and successful deployment of our domestic violence solution in other nations globally. Expanding our relationship with Finland through a new program within only a few short months from original project launch demonstrates the trust the nation's Ministry of Justice places in SuperCom. This also acts as another testament to the undeniable effectiveness and reliability of our solutions. This new program underscores our dedication to providing cutting-edge security solutions to our valued customers and marks yet another milestone in our commitment to creating safer communities around the world."

To view the full press release, visit

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More



In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.


Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Thursday's trading session at $0.4319, off by 2.0635%, on 29,030 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.4051/$3.302.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, "Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation," please visit:

More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare diseases, is a key priority for the U.S. Food & Drug Administration. As part of that process, the agency can grant Orphan Drug Designation (ODD) to a drug or biological product being developed to prevent, diagnose or treat a rare disease or condition.

This designation is intended to spark innovation among biotech companies that are developing treatments for these patient populations, which by definition affect fewer than 200,000 people in the U.S., by providing incentives such as tax credits, user-fee exemptions and up to seven years of market exclusivity after FDA approval. Last month, Genprex Inc. (NASDAQ: GNPX) was granted FDA orphan drug designation for its REQORSA(R) immunogene therapy in development for the treatment of small cell lung cancer (SCLC).

Genprex Inc. (GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Thursday's trading session at $0.4298, off by 4.0625%, on 297,050 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.4011/$1.94.

Recent News

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0)

The QualityStocks Daily Newsletter would like to spotlight Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0).

In September 2023, Sekur Private Data announced that it had signed a distribution agreement with VYRE Network, a leading news-based streaming channel and website, for the Sekur suite of solutions

The company has no debt and no convertible equity

Sekur Private Data in June 2023 announced that it is on track to launch Sekur Enterprise Solutions, its new product for SMBs, large enterprises and government organizations

The company plans to launch SekurIdentity, its new identity theft protection solution, in 2024

Sekur Private Data plans international business expansions in Latin America, Australia and Europe in 2024

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Customer information is completely confidential and safely stored in Switzerland using military grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations organizations, as well as many corporations and governmental organizations. All user data is protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offer some of the strongest privacy protection in the world for both individuals and organizations.

The company owns 100% of its own infrastructure and, unlike its competitors, does not rely on third party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google cloud infrastructure.

Sekur Private Data has chosen Switzerland to locate its data storage because of the country’s neutrality, independence, strong privacy laws, long standing political stability and excellent international relations. Switzerland is also home to several large multinational corporations and is ranked as having one of the strongest and most competitive economies in the world.

The company is headquartered in Toronto, Ontario.


Sekur Private Data distributes a privacy communications suite offering encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application. All solutions cater to consumers, SMBs, enterprises and governments.

  • SekurMail® is an encrypted email service offering a private, safe and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties. Its encryption and other security measures prevent messages from being intercepted, modified or tampered with, either in transit or while stored. SekurMail empowers the client to access information and communicate with anyone in the world, regardless of geographical or political barriers.
  • SekurVPN® creates a secure, encrypted connection between the client’s device and the Internet, giving clients access to the web safely and privately by routing their connections through a server and hiding their online actions. All the data sent and received is hidden from prying eyes. This includes the clients’ Internet Service Providers, as well as potential hackers and even government surveillance agencies. It can also help clients bypass geographical restrictions and censorship.
  • SekurMessenger® is a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording and file transfer via any mobile device, tablet or desktop computer. Communications are transmitted only within secure servers. It’s designed for organizations that need to protect their flow of information and secure their communications with customers and partners. SekurMessenger is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged. It works for both licensed users of the app and intended message recipients who do not have the app.

Market Opportunity

An analysis from ReportLinker forecasts that the global cybersecurity market will grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors that are driving cybersecurity market growth, according to the report.

The global data privacy software market was estimated to be worth $1.68 billion in 2021 and is expected to grow from $2.36 billion in 2022 to $25.85 billion by 2029, achieving an eye-popping 40.8% CAGR during the forecast period, according to a Fortune Business Insights report titled ‘Data Privacy Software Market 2022-2029’.

The widespread shift toward remote working culture, evolving government data privacy regulations and the rapidly increasing adoption of Internet-of-Things devices are among the major factors propelling market growth, per the report.

Management Team

Alain Ghiai is founder, CEO and Director at Sekur Private Data. He also founded GlobeX Data S.A. (GDSA) in 2007 and has served as Director and CEO since then. He founded GlobeX Data Inc. (GlobeX US) in August 2012 and has served as Director and CEO since that time. He attended the California College of Arts in San Francisco, where he earned a Bachelor of Architecture. He has over 15 years of experience in the software industry and was instrumental in taking Sekur Private Data public in July 2019.

Scott Davis, CPA, CGA, is CFO at Sekur Private Data. He is also a partner at Cross Davis & Company LLP Chartered Professional Accountants. His experience includes CFO positions at several companies listed on the TSX Venture Exchange. He spent four years at Appleby as an Assistant Financial Controller. Prior to that, he spent two years at Davison & Company Chartered Professional Accountants as Auditor, five years with Pacific Opportunity Capital as Accounting Manager and two years at Jacobson Soda and Hosak, Chartered Professional Accountants. He obtained his CPA, CGA in 2003.

Learn more about the company’s management team by visiting its corporate page.

Sekur Private Data Ltd. (OTCQB: SWISF), closed Thursday's trading session at $0.138, off by 8%, on 96,010 volume. The average volume for the last 3 months is 84,635 and the stock's 52-week low/high is $0.027/$0.15.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

Americans are taking to permanent jewelry — a trend where jewelry is welded together rather than held by a clasp — at increasing rates. Permanent jewelry first gained traction on social media and soon attracted the attention of brands such as Italian firm Atelier VM as well as Catbird in New York City, which launched permanent jewelry such as welded bracelets into the mainstream. Although the concept of permanent jewelry has technically been around for centuries, the trend has gathered steam in the U.S. in recent years as everything from small hair salons and farmers' markets to major beauty brands now offer this service. The idea is simple enough: rather than using a clasp to connect the opposing ends of an anklet, necklace or bracelet, the ends are welded together in a quick and painless process. Furthermore, since the jewelry technically isn't "permanent" and can be cut off as easily as it was welded together, customers can remove the pieces or replace them with other pieces whenever they please. If you have questions about permanent jewelry or anything about the jewelry making process, it would be prudent to contact reputable jewelry makers such as GEMXX Corp. (OTC: GEMZ) so that you can make an informed decision before investing your hard-earned money in a piece of jewelry that may have sentimental value to you or your loved one.

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.


GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Thursday's trading session at $0.029, off by 3.3333%, on 141,801 volume. The average volume for the last 3 months is 34,325 and the stock's 52-week low/high is $0.023/$0.998.

Recent News

RJD Green Inc. (OTC: RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (OTC: RJDG) .

RJD Green (OTC: RJDG), a holding company, manages assets in three diverse, high-growth industries in separate "recession-resistant" markets, including construction, digital healthcare services and environmental solutions. "RJDG formed its specialty construction division to focus on industrial contracting, building material products and construction services. The company's first acquisition, Silex Interiors, is a manufacturer, distributor and installer of countertops, cabinets, and related bathroom and kitchen products with a large target market comprising commercial contractors, residential builders, new and renovation contractors, and retail customers. With the aim of filling a market niche between ‘big box' stores and smaller retail distributors, RJDG plans to launch Silex into major national markets through internal expansion, franchising and supplementary acquisitions. Silex was awarded a large contract for natural stone countertops and cabinets in May 2023 that is expected to generate over $850,000 in revenue," a recent article reads. "This significant commercial contract awarded to Silex continues the revenue progression in our commercial business segment and reflects geographic expansion," RJD Green CEO Ron Brewer is quoted as saying.

To view the full article, visit

RJD Green Inc. (OTC: RJDG) is a holding company focused on managing portfolio assets while actively exploring potential acquisitions and opportunities in diversified industries. The company currently operates in three divisions: RJD Green Healthcare Division, Earthlinc Environmental Solutions and Silex Holdings Inc.

The company’s corporate management team has a history of success in both public and private arenas, with diverse enterprise experience that includes RJD Green’s three current market sectors of focus. Corporate overhead is maintained at minimal operating cost, with each officer and team member maintaining daily management responsibility for specific operating divisions and entities.

Each acquisition and asset is operated as a separate profit center, with the recognition that, in small business operations, proficiency and frugal budgeting are required to maximize profitability. The RJD Green team excels in working collaboratively with the company’s business partners, creating common efforts for reaching mutual reward from its relationships.

The company is headquartered in Tulsa, Oklahoma.

Business Divisions

RJD Green Healthcare Division

Through this division, the company has developed a business model that utilizes the healthcare industry experience and extensive industry relationships of its management team. RJD Green’s leadership has long-term relationships with many key providers within the service sectors of the healthcare industry.

The first RJD Green Healthcare Division services acquisition was IoSoft Inc., a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers. The IoSoft team has years of experience and relationships within the more than a million providers in the healthcare market.

Earthlinc Environmental Solutions

This division was formed to promote green applied technologies and offer environmental services in North America. Its focus is on performance-driven solutions for environmental-based issues.

The first acquisition, Animal Waste Management, is a patented technology that is fully developed and entering the market for waste processing on commercial chicken and hog farms. Development was supported by the University of Arkansas and the Missouri Department of Natural Resources.

The acquired technology controls the liquid, solid and gas waste generated, creating an odorless, clean, bacteria-free by-product that can be used for animal feed filler, while allowing the water to be reused as ground water on the farm.

Silex Holdings Inc.

This division was formed for the purpose of acquiring and managing high growth assets and business enterprises. Its operations are focused on acquisitions in specialty industrial contracting, building material products and construction services.

Acquisitions are modeled to offer immediate growth, such as a unique geographical or proprietary market niche or other differentiating quality, and are synergistic in corporate management and administration, as well as sales and marketing.

The company’s first acquisition through this division, Silex Interiors, is a manufacturer, distributor and installer of countertops, cabinets and related kitchen and bath products. Silex is modeled for expansion into major markets nationally through internal expansion, acquisition and franchising.

Market Opportunity

According to a report from, the global healthcare services market is expected to grow from $6.8 billion in 2021 to $10.4 billion in 2026 at a CAGR of 8.6%. The report attributed the forecast growth primarily to healthcare companies restructuring their operations as a result of lasting challenges presented by the COVID-19 pandemic.

Research firm Verdantix reported the environmental services market was worth an estimated $35.2 billion in 2022 and is expected to reach a value of $50.6 billion by 2029, marking a CAGR of 6.3% for the forecast period. Verdantix identified factors driving growth to include changing environmental compliance regulations, rising demand for infrastructure projects and increased ESG reporting scrutiny.

In 2021, Icon Market Research estimated the global specialty trade contractors market at $3.9 billion, forecasting that it will reach $5.7 billion by 2028 at an expected CAGR of 9.2% through the identified period.

Management Team

Ron Brewer is CEO of RJD Green. He has served as a corporate officer in both public and private companies, including as president of Mid-Continent Companies. He has experience in all three industries represented by the company’s divisions. He has provided management and guidance to five environmental services and technology companies, as well as guiding business development services in healthcare for hospitals, practice assistance and various service providers in the sector. He has also developed three separate companies in the same construction products sector.

Jerry Niblett is COO at RJD Green. He has over 19 years of management success in oil and gas operations at both corporate and small-cap enterprises. His corporate employment history includes Dominion Energy, Texaco, Shell and Sunoco Pipeline LP. He has worked in multiple energy sectors, including petro-chemical refining, natural gas compression, crude oil pipeline and storage, oil and gas exploration, and oil and gas products and services business development. He holds a bachelor’s degree in Total Quality Management, graduating with honors.

John Rabbitt is CFO at RJD Green. He has worked at Fortune 500 firms including Pillsbury, PepsiCo and CPA firm Ernst and Ernst. He played a key role in the growth of MEI Corp. from $20 million annual revenue to $850 million annually in nine years, at which time it was acquired by PepsiCo. He has a proven track record in both fast-growth and turnaround environments, serving in CEO/COO and CFO positions for firms ranging from $5 million to $300 million annual revenue. His education includes degrees in accounting and business from Drake University and PepsiCo’s Management Institute.

RJD Green Inc. (OTC: RJDG), closed Thursday's trading session at $0.00495, off by 1%, on 122,175 volume. The average volume for the last 3 months is 251,577 and the stock's 52-week low/high is $0.0041/$0.01315.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.